Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Timab Magnesium, a subsidiary of Groupe Roullier, is a global specialist in magnesium-based products for the pharmaceutical, food, and industrial sectors. The company produces high-purity magnesium oxide, magnesium hydroxide, and magnesium carbonate used as active pharmaceutical ingredients (APIs) and excipients. Their pharmaceutical grade products, often marketed under the PHARMAG brand, are utilized in applications such as antacids, laxatives, and mineral supplements. With a vertically integrated supply chain and dedicated R&D centers, Timab Magnesium ensures high quality and regulatory compliance for global healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Timab Magnesium.